NCT05989191View on ClinicalTrials.gov

Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires

Active, not recruitingOBSERVATIONAL

Enrollment

690

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

November 30, 2024

Study Completion Date

March 30, 2025

Conditions

Cancer

Trial Locations (2)

54519

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

75005

Institut Curie, Paris

All Listed Sponsors

lead

Institut Curie

OTHER